Health & Pharm General

Hospitals Adopt Voir Bougie® to Enhance Airway Management Safety

🕔5/13/2025 6:00:10 AM

Two of Sydney’s leading hospitals — Nepean Hospital and Concord Hospital — have officially adopted the Voir Bougie®, a breakthrough in tracheal intubation safety, into their clinical protocols.

Read Full Article

Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market

🕔5/12/2025 4:35:33 PM

Australian-Singaporean regenerative medicine company Osteopore Limited (ASX:OSX) is pleased to announce that the Company has secured a non-exclusive 3-year distribution arrangement with Kelyniam Global, Inc

Read Full Article

Jobma Wins SourceForge Spring 2025 Top Performer Award

🕔5/12/2025 8:00:49 AM

Jobma, a leading AI hiring platform, announced that it has been awarded the Spring 2025 Top Performer award in the Video Interviewing Software category, presented by SourceForge, the world’s largest platform for B2B software review and comparison, reaching nearly 20 million visitors monthly.

Read Full Article

A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases

🕔5/9/2025 8:53:55 PM

The 21st edition of Sustainability Through Science and Technology Summit 2025 (SIPS 2025), dedicated to Prof. Aaron Ciechanover, Nobel Laureate in Chemistry, to be held in Cebu, Philippines, from 17-20 November 2025, has confirmed the participation of Davis Joseph as an invited summit plenary lecturer for his recent ground-breaking discovery of the common master switch for numerous brain-related diseases.

Read Full Article

Nanopharmaceutics Announces NanoDOX® Hydrogel will be Tested in The University of Western Australia Clinical Trial

🕔5/9/2025 2:55:46 PM

Nanopharmaceutics, Inc., a clinical-stage pharmaceutical development company, announced NanoDOX® 1% Doxycycline Monohydrate hydrogel with oral doxycycline will be tested in male partners with Genital Mycoplasmas in The University of Western Australia Clinical Trial "Efficacy of treating asymptomatic infections to restore fertility: The RESETTER Study: A prospective, single-centre, multi-site clinical trial of the effect of a combined partner treatment program for clearance of asymptomatic genital Mycoplasmas on unexplained fertility and clinical pregnancy rates " (Registration number: ACTRN12624001180505).

Read Full Article

Dr. Kinnar Shah Stands at Forefront of Sydney’s Cosmetic Dentistry Receives Yet Another Award from ThreeBestRated®

🕔5/7/2025 11:00:00 PM

ThreeBestRated® is a multinational directory that works tirelessly to identify the top businesses across various fields and take them to a wider set of audiences.

Read Full Article

Penta Security Announces Integration with Buy with AWS, Offering Simplified Procurement for AWS Customers on its Website

🕔5/7/2025 12:00:00 PM

Penta Security, a leading cyber security company and provider of web application security in the Asia-Pacific region, announced its integration with Buy with AWS, a new feature now available through AWS Marketplace, a digital catalog that helps you find, buy, deploy, and manage software, data products, and professional services from thousands of vendors.

Read Full Article